Rana Harb

Ipilimumab plus nivolumab and DNA-repair defects in AR-V7-expressing metastatic prostate cancer

Karim Boudadi, Daniel L. Suzman, Valsamo Anagnostou et al. · Oncotarget · 2018 · 157 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Nivolumab plus ipilimumab, with or without enzalutamide, in AR‐V7‐expressing metastatic castration‐resistant prostate cancer: A phase‐2 nonrandomized clinical trial

Eugene Shenderov, Karim Boudadi, Wei Fu et al. · The Prostate · 2021 · 69 citations · Full text

Medicine, Oncology, Pharmacology +17

Transperineal prostate biopsy with cognitive magnetic resonance imaging/biplanar ultrasound fusion: description of technique and early results

Michael A. Gorin, Alexa Meyer, Michael E. Zimmerman et al. · World Journal of Urology · 2019 · 56 citations

Medicine, Radiology, Urology +14

A pilot trial of pembrolizumab plus prostatic cryotherapy for men with newly diagnosed oligometastatic hormone-sensitive prostate cancer

Ashley E. Ross, Paula J. Hurley, Phuoc T. Tran et al. · Prostate Cancer and Prostatic Diseases · 2019 · 53 citations

Medicine, Oncology, Urology +13

Pharmacodynamic study of the oral hedgehog pathway inhibitor, vismodegib, in patients with metastatic castration-resistant prostate cancer

Benjamin L. Maughan, Daniel L. Suzman, Brandon Luber et al. · Cancer Chemotherapy and Pharmacology · 2016 · 31 citations · Full text

Medicine, Oncology, Pharmacology +16